Abstract:Background: Glutathione (GSH), a highly abundant thiol compound within cells, plays a critical role in physiological processes and exhibits close correlation with cancer. Among molecular imaging technologies, most probes have relatively short emission wavelengths and lack photoacoustic imaging (PA) capability, resulting in the inability to obtain tissue images with high penetration depth. The presence of GSH in the tumor microenvironment neutralizes ROS, diminishing the therapeutic effect of PDT, thus resulting in often unsatisfactory therapeutic efficacy. Therefore, it is imperative to develop a dual-modal probe for the detection of GSH and the diagnosis and treatment of cancer. Results: In this study, we synthesized a novel dual-modal probe, Cy-Bio-GSH, utilizing near-infrared fluorescence (NIRF) and photoacoustic (PA) imaging techniques for GSH detection. The probe integrates cyanine dye as the fluorophore, nitroazobenzene as the recognition moiety, and biotin as the tumor-targeting moiety. Upon reacting with GSH, the probe emits NIR fluorescence at 820 nm and generates a PA signal. Significantly, this reaction activates the photodynamic and photothermal properties of the probe. By depleting GSH and employing a synergistic photothermal therapy (PTT) treatment, the therapeutic efficacy of photodynamic therapy (PDT) is remarkably enhanced. In-vivo experiments confirm the capability of the probe to detect GSH via NIRF and PA imaging. Notably, the combined tumor-targeting ability and PDT/PTT synergistic therapy enhance therapeutic outcomes for tumors and facilitate their ablation. Significance: A novel tumor-targeting and dual-modal imaging probe (Cy-Bio-GSH) is synthesized, exhibiting remarkable sensitivity and selectivity to GSH, enabling the visualization of GSH in cells and the differentiation between normal and cancer cells. Cy-Bio-GSH enhances PDT/PTT with effective killing of cancer cells and makes the ablation of tumors in mice. This work represents the first tumor-targeting probe for GSH detection, and provides crucial tool for cancer diagnosis and treatment by dual-modal imaging with improved PDT/PTT synergistic therapy.

A GLUT1 inhibitor-based fluorogenic probe for Warburg effect-targeted drug screening and diagnostic imaging of hyperglycolytic cancers

GLUT1-mediated Selective Tumor Targeting with Fluorine Containing Platinum(ii) Glycoconjugates.

A Multifunctional Near-Infrared Fluorescent Probe for in Vitro and in Vivo Imaging of Γ-Glutamyltranspeptidase and Photodynamic Cancer Therapy

Novel Dual-Function Near-Infrared II Fluorescence and PET Probe for Tumor Delineation and Image-Guided Surgery.

Identification of Novel Inhibitors of GLUT1 by Virtual Screening and Cell-Based Assays

Cyanine-based 1-amino-1-deoxyglucose as fluorescent probes for glucose transporter mediated bioimaging

Identification of a Novel GLUT1 Inhibitor with in Vitro and in Vivo Anti-Tumor Activity.

Metabolic Imaging of Tumors Using Intrinsic and Extrinsic Fluorescent Markers

Bioorthogonal Light-Up Fluorescent Probe Enables Wash-Free Real-Time Dynamic Monitoring of Cellular Glucose Uptake

Development and Characterization of a Fluorescent Probe for GLS1 and the Application for High-Throughput Screening of Allosteric Inhibitors.

Targeted Delivery of a Γ-Glutamyl Transpeptidase Activatable Near-Infrared-Fluorescent Probe for Selective Cancer Imaging

A water-soluble fluorescent probe for the determination of γ-glutamyltransferase activity and its application in tumor imaging

Fluorescent and Quantitative Mitochondrial Redox Imaging of Tumor Targeted by Octa-RGD Probe

Glucose-lightened Upconversion Nanoprobes for Accurate Cellular-Discrimination Based on Warburg Effect.

Imaging Γ-Glutamyltranspeptidase for Tumor Identification and Resection Guidance Via Enzyme-Triggered Fluorescent Probe.

Nuclear Imaging of Glucose Metabolism: Beyond 18F-FDG

Computer-assisted Identification of Novel Small Molecule Inhibitors Targeting GLUT1

Detection of glucose transporter 1 in living cells for assessment of tumor development and therapy using an electrochemical biosensor

Glutathione-activated biotin-targeted dual-modal imaging probe with improved PDT/PTT synergistic therapy

Tumor cell membrane-coated continuous electrochemical sensor for GLUT1 inhibitor screening

18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers